MAGAN SHIPP: Open Payments
NPI 1285016279 · BATESVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,158 in 65 payments from 14 companies in 2025. Trend: 2023 $1,076 · 2024 $1,064 · 2025 $1,158
Food & beverage: $1,158
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $235 |
| Novo Nordisk Inc | 7 | $212 |
| AstraZeneca Pharmaceuticals LP | 8 | $190 |
| Lilly USA, LLC | 10 | $131 |
| PFIZER INC. | 5 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $83 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Astellas Pharma US Inc | 1 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: Ozempic, MOUNJARO, QULIPTA, TRINTELLIX, FARXIGA, VRAYLAR, NURTEC ODT, AIRSUPRA.
Industry payments across MS — which companies pay providers there.
